Oscient Pharmaceuticals Corp (OSCI)

CAPS Rating:

A commercial-stage biopharmaceutical company marketing two FDA-approved products with its national primary care sales force, a cardiovascular product, ANTARA(r) capsules and a fluoroquinolone antibiotic, FACTIVE(r) tablets.